Palliative pelvic exenteration for patients with gynecological malignancies

被引：20

作者：

Guimares, Gustavo Cardoso ^{[1
]}

Baiocchi, Glauco ^{[2
]}

Ferreira, Fabio Oliveira ^{[1
]}

Kumagai, Lillian Yuri ^{[2
]}

Fallopa, Carlos Chaves ^{[2
]}

Aguiar, Samuel ^{[1
]}

Rossi, Benedito Mauro ^{[1
]}

Soares, Fernando Augusto ^{[3
]}

Lopes, Ademar ^{[1
]}

机构：

[1] AC Camargo Canc Hosp, Dept Pelv Surg, BR-01509010 Sao Paulo, Brazil

[2] AC Camargo Canc Hosp, Dept Gynecol, BR-01509010 Sao Paulo, Brazil

[3] AC Camargo Canc Hosp, Dept Pathol, BR-01509010 Sao Paulo, Brazil

来源：

ARCHIVES OF GYNECOLOGY AND OBSTETRICS | 2011年 / 283卷 / 05期

关键词：

Pelvic exenteration; Gynecologic neoplasm; Palliative surgery; Palliative treatment; RECURRENT CERVICAL-CARCINOMA; UTERINE CERVIX; PHASE-III; EXPERIENCE; CANCER; SURGERY; PACLITAXEL; CISPLATIN; DIVERSION; URINARY;

D O I：

10.1007/s00404-010-1544-8

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Purpose To evaluate the results of palliative pelvic exenteration in patients with gynecologic tumors. Methods A retrospective analysis was carried out in 13 patients from January 2000 to December 2007. The procedure was considered palliative because of distant metastatic disease or unresectable pelvic wall disease. Patients presented with bleeding, fistula, malodorous discharge or untreatable pain. Result Overall complication rate was 38.4%. Mean follow-up time was 8 months. Actuarial 2 years overall survival was 15.4%. Six patients survived more than 5 months and three more than 12 months. All achieved symptoms control and favorable impact in quality of life. Two patients are with stable disease after 26 and 28 months. Conclusions Palliative exenteration is a procedure with high morbidity and mortality rates and should only be offered to highly selected patients. The role of exenterative surgery in relieving severe symptoms in patients with incurable disease is yet to be established.

引用

页码：1107 / 1112

页数：6

共 32 条

[1]

Beachamp T., 2001, PRINCIPLES BIOMEDICA, V5th

[2] Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA [J].

Berek, JS ;

Howe, C ;

Lagasse, LD ;

Hacker, NF .

GYNECOLOGIC ONCOLOGY, 2005, 99 (01) :153-159

[3]

BRUNSCHWIG A, 1948, CANCER-AM CANCER SOC, V1, P177, DOI 10.1002/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO

[4]

2-A

[5] Part 1: Surgical palliation of advanced illness - What's new, what's helpful [J].

Cady, B ;

Easson, A ;

Aboulafia, AJ ;

Ferson, PF .

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 200 (01) :115-127

[6] Surgical palliation in advanced disease: recent developments. [J].

Dunn G.P. .

Current Oncology Reports, 2002, 4 (3) :233-241

[7] Double-barreled wet colostomy is a safe option for simultaneous urinary and fecal diversion. Analysis of 56 procedures from a single institution [J].

Guimaraes, GC ;

Ferreira, FO ;

Rossi, BM ;

Aguiar, S ;

Zequi, SC ;

Bachega, W ;

Nakagawa, WT ;

Fonseca, FP ;

Sarkis, AS ;

Lopes, A .

JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (03) :206-211

[8] Laterally extended endopelvic resection Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall [J].

Höckel, M .

GYNECOLOGIC ONCOLOGY, 2003, 91 (02) :369-377

[9] Pelvic exenteration for gynaecological tumours:: achievements and unanswered questions [J].

Hoeckel, Michael ;

Dornhoefer, Nadja .

LANCET ONCOLOGY, 2006, 7 (10) :837-847

[10] Ethics of palliative surgery in patients with cancer [J].

Hofmann, B ;

Håheim, LL ;

Soreide, JA .

BRITISH JOURNAL OF SURGERY, 2005, 92 (07) :802-809

← 1 2 3 4 →